STOCK TITAN

Ceribell (CBLL) SEC Filings, Feb-Mar 2026

CBLL NASDAQ

CeriBell, Inc. filings document the regulatory record of a medical technology company commercializing point-of-care EEG systems for neurological monitoring. Its Form 8-K reports include furnished financial results, FDA clearance events for the Clarity seizure-detection algorithm and other Ceribell System indications, and material agreements related to facility leases and headband supply arrangements.

The company’s proxy materials and governance filings cover annual meeting matters, board composition, committee assignments, director compensation arrangements, indemnification agreements, and related shareholder voting procedures. These disclosures provide formal records of Ceribell’s operating updates, governance structure, contractual obligations, and public-company reporting events.

Rhea-AI Summary

Ceribell, Inc. Chief Technology Officer Raymond Woo reported a set of option exercises and related share sales in Ceribell stock. On March 2, 2026, he exercised multiple stock options to acquire common shares and then sold 11,112 shares of common stock in open-market transactions under a pre-arranged Rule 10b5-1 trading plan adopted on May 28, 2025. The reported sale prices were based on weighted-average prices within ranges from $18.10 to $18.41 per share. After these transactions, Woo directly held 166,912 shares of Ceribell common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.31%
Tags
insider
-
Rhea-AI Summary

CBLL reports Form 144 notice of affiliate sales. The filing lists multiple sales by Xingjuan Chao, including 25,000 shares on 12/04/2025 for 470,532.50, 79,000 shares on 01/05/2026 for 1,680,124.43, 39,000 shares on 02/04/2026 for 786,392.36, and 2,084 shares on 02/23/2026 for 41,251.74.

The form also lists planned option-related sales and grants with dates and share counts, including 9,821 shares (09/25/2024), 4,179 shares (05/15/2025), and 25,000 shares (03/03/2026).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.41%
Tags
other
-
Rhea-AI Summary

CBLL filed a Rule 144 resale notice listing 4,560 shares of common stock to be sold on 03/03/2026. The filing also lists recent officer sales by David J. Foehr, including 5,265 shares on 12/03/2025 for $88,609.95, 5,556 shares on 01/05/2026 for $125,565.60, 5,556 shares on 02/03/2026 for $111,120.00, 569 shares on 02/23/2026 for $11,263.07, and 781 shares on 02/24/2026 for $15,604.38.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.41%
Tags
other
Rhea-AI Summary

Ceribell, Inc. director Rebecca B. Robertson reported a proposed sale of 827 common shares, with an aggregate market value of $14,720.60 and an approximate sale date of March 3, 2026. The shares were acquired through restricted stock vesting on March 1, 2026, as compensation. The notice records a Rule 10b5-1 plan adoption date of March 14, 2025. During the past three months, Robertson reported sales of 5,000 shares for gross proceeds of $100,000 on December 8, 2025, and 2,500 shares for $54,725 on January 2, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.41%
Tags
other
-
Rhea-AI Summary

Raymond Woo filed a Form 144 reporting proposed and recent sales of Common stock. The notice lists proposed sales of 9,640 and 1,472 shares dated 03/02/2026, and reports recent sales of 11,112 shares on 01/02/2026, 11,112 shares on 02/02/2026, and 705 shares on 02/23/2026. The entries include cash amounts tied to those past sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.73%
Tags
other
-
Rhea-AI Summary

Ceribell, Inc. senior vice president of finance David Foehr sold 1,350 shares of common stock in open-market transactions. The sales involved 781 shares at an average price of $19.98 on February 24, 2026 and 569 shares at $19.79 on February 23, 2026.

According to the disclosure, these shares were sold to cover tax withholding obligations tied to vesting restricted stock units, and were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 4, 2025. After these sales, Foehr directly owned 17,550 common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.32%
Tags
insider
Rhea-AI Summary

Ceribell, Inc. Chief Revenue Officer Joseph S. Manni reported an open-market sale of 768 shares of common stock on February 23, 2026 at $19.79 per share. According to the notes, these shares were sold to cover tax withholding obligations from vesting restricted stock units. After this transaction, he directly owned 26,933 shares, which includes 300 shares acquired under the company’s Employee Stock Purchase Plan on January 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.32%
Tags
insider
-
Rhea-AI Summary

Ceribell, Inc. Chief Technology Officer Raymond Woo reported an open-market sale of 705 shares of common stock at $19.79 per share. According to the disclosure, the shares were sold to cover tax withholding obligations related to the vesting of restricted stock units. After this transaction, Woo directly holds 166,912 shares of Ceribell common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.32%
Tags
insider
-
Rhea-AI Summary

Ceribell, Inc. Chief Financial Officer Scott Blumberg reported an open-market sale of 808 shares of common stock on February 23, 2026 at a price of $19.79 per share. The sale was made to cover tax withholding obligations related to vesting restricted stock units. Following this transaction, he directly holds 118,334 shares, which includes 300 shares acquired under Ceribell's Employee Stock Purchase Plan on January 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.32%
Tags
insider
Rhea-AI Summary

Ceribell, Inc. President and CEO Chao Xingjuan reported an open-market sale of 2,084 shares of common stock on February 23, 2026 at $19.79 per share. According to the disclosure, these shares were sold to cover tax withholding obligations arising from the vesting of restricted stock units.

After this transaction, she directly owned 725,164 common shares. The filing also notes an indirect holding of 369,088 shares through the ACP 2021 Trust, where she is a co-trustee and may be deemed to share beneficial ownership, while disclaiming beneficial ownership beyond her pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.32%
Tags
insider

FAQ

How many Ceribell (CBLL) SEC filings are available on StockTitan?

StockTitan tracks 185 SEC filings for Ceribell (CBLL), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Ceribell (CBLL)?

The most recent SEC filing for Ceribell (CBLL) was filed on November 17, 2026.